BioArctic and Eisai team up on Alzheimer’s disease candidate BAN2802

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) has entered into a new research evaluation agreement with Eisai Co., Ltd. The collaboration focuses on BAN2802, a ... Read More